1973
Discovered
by biochemist Loren Pickart — 50+ years of lab research. The science came before the hype.
~60%
Drop By Age 60
your natural GHK falls from ~200 ng/mL at age 20 to ~80 ng/mL by 60 — the decline that started it all
~4,000
Genes It Can Shift
in lab studies it switches thousands of human genes up or down — "resetting" cells toward a younger pattern
0
FDA-Approved Medical Uses
legal as a cosmetic ingredient (Copper Tripeptide-1); the injectable has never been reviewed — unpatentable, so no company will fund the trial
GHK-Cu isn't one claim with one verdict. It's a single molecule pointed at three different goals — and the evidence is very different for each. The lab and animal science is genuinely deep (5 decades), but the human proof is strongest for skin, mostly old-and-animal for wounds, and thinnest for hair. This chart sets honest expectations before the detail below. (Per PubMed; see footer for citations and DOIs.)
Skin & Anti-Aging
The #1 real-world use. Human cosmetic trials are encouraging — but small and industry-sponsored, and a serum only works if it can actually get through your skin.
Wound Healing & Repair
*The deepest science — but mostly animal & lab (incl. a controlled animal trial). Modern human wound RCTs are thin.
Hair Growth
The most over-sold use. Copper peptide only shows up as one ingredient inside injectable hair "cocktails" — never tested alone in people.
GHK is three linked amino acids (glycine–histidine–lysine) that grab a copper ion to become GHK-Cu. It's not a foreign drug — it already circulates in your blood, saliva, and urine. The story started when it made old tissue behave like young tissue in a dish, and five decades of lab work have been chasing that ever since. (According to PubMed.)
Born in 1973
"Old → Young"
Pickart found an activity in human blood protein that made old human liver tissue synthesize proteins like young tissue. That activity was GHK — the finding that launched the whole field.
It's Already In You
200 → 80
Natural plasma GHK averages ~200 ng/mL at age 20 and falls to ~80 ng/mL by 60 (ng/mL). The idea behind supplementing: top up what your aging body stops making.
Switches ~4,000 Genes
~4,000
In gene-profiling studies GHK turns thousands of human genes up or down — favoring tissue repair, antioxidant defense, and DNA repair. Researchers describe it as "resetting" cells toward a healthier state.
Builds the Skin's Scaffolding
↑ Collagen
It stimulates collagen, elastin, and glycosaminoglycans (the skin's cushioning), attracts repair cells, grows new blood vessels, and calms inflammation — the toolkit behind both skin and wound effects.
This is what most people actually buy GHK-Cu for: a topical anti-aging serum. The human studies are real and encouraging — firmer, denser skin with fewer fine lines — but they're small and run by the companies selling the product. And there's an honest catch most ads skip: the molecule is so water-loving it barely crosses intact skin on its own, so the formula has to be built to deliver it.
| # |
Study |
Type / n |
What It Found |
| 1 |
GHK-Cu facial cream on aged / photodamaged skin (Leyden et al., cosmetic study)
|
Cosmetic trial
n=71 women, 12 wks |
Improved
Increased skin density & thickness, reduced fine lines and wrinkle depth, improved firmness & clarity. Industry-sponsored. |
| 2 |
GHK-Cu eye cream vs placebo & vitamin K cream (periorbital area)
|
Cosmetic trial
n=41 women, 12 wks |
Beat both
Outperformed placebo and vitamin-K cream for crow's-feet lines and skin density. Industry-sponsored. |
| 3 |
Collagen response: copper peptide vs vitamin C vs retinoic acid creams
|
Cosmetic comparison |
70% vs 50% vs 40%
Improved collagen in ~70% of users vs ~50% (vitamin C) vs ~40% (retinoic acid) — but a sponsored, non-independent comparison. |
| 4 |
Can it even get in? Skin-permeation study (microneedles vs intact skin)
|
Lab (human skin) |
The catch
"Almost no peptide or copper permeated through intact human skin." It needed microneedles to get through — plain serums face this barrier. |
This is the original research lane and the deepest science — GHK-Cu speeds healing, calms inflammation, and grows new blood vessels. The honest caveat: most of it is animal and lab work (including a controlled animal trial). It's strong, consistent, decades-deep preclinical evidence — but not the same as modern human wound trials, which remain thin.
Faster Wound Closure (animal RCT)
Faster
In a randomized rabbit study, topical copper-tripeptide healed open wounds significantly faster than zinc oxide and untreated control at days 7, 14 and 21 — with the best new-blood-vessel growth.
Pulls Copper to the Wound
9×
A GHK-loaded collagen dressing raised copper at the wound site 9-fold and sped healing in rats — copper itself is a healing cofactor, and GHK delivers it where it's needed.
Calms the Fire
↓ IL-6 / TNF
In human skin cells, GHK-Cu lowers inflammatory signals (TNF-α–driven IL-6) and dials down the scar-driving signal TGF-β1 — healing that's less inflamed and less scarred.
Newest: Wound Hydrogel
2025
A 2025 food-derived GHK-Cu hydrogel dressing was antibacterial, anti-inflammatory and pro-blood-vessel for infected wounds — promising, but still a preclinical (lab/animal) study.
Copper peptide is marketed hard for hair — but here's the catch that ads bury: in every human study, GHK-Cu is just one ingredient inside a multi-growth-factor injection. The cocktails do seem to work, but you cannot credit the result to the copper peptide alone. There is no human trial of GHK-Cu by itself for hair.
Always in a Cocktail
1 of 6
In the studied injectable hair formulas, copper tripeptide-1 is one of six ingredients (alongside VEGF, FGF, IGF, KGF and thymosin β4). Its solo contribution is unknown.
The Cocktail's Number
83%
In a 1,000-patient open-label study of that injection, 83% had less hair fall on the pull test, with more terminal hairs and a significant 1-year hair-count increase (p=0.002) — but no placebo group.
Mouse + Lab Safe
Preclinical
The same formula grew hair in mice and was non-toxic to human skin cells — the authors said it "warrants a [human] trial." Encouraging, but animal/lab stage.
What Pickart Reports
Follicle Size ↑
Reviews credit GHK-Cu with enlarging hair follicles and improving hair-transplant survival — but this rests on mechanism and older reports, not a modern controlled hair trial.
If you're deciding whether to spend on copper peptide for your skin, here's what it runs against the proven options. The topical serum is the cheap, legal, sensible entry point; the injectable is pricier and gray-market.
Mainstream Use
Copper-Peptide Serum (topical)
$15–120
per bottle (~1–3 months)
Give it 8–12 weeks; pick one formulated to penetrate
Most Proven
Tretinoin (retinoic acid, Rx)
$20–50
per month, generic
The gold-standard anti-aging Rx — decades of RCTs
OTC Retinol
$15–40
per bottle
Gentler OTC cousin of tretinoin; strong evidence
Gray-Market
Compounded Injectable GHK-Cu
$60–80
per vial (research-grade ~$0.55–0.85/mg)
Not FDA-approved; no established human dose
In-Office
Microneedling / PRP
$200–1,500
per session (series usually needed)
Procedure route to the same collagen goal
There's no FDA-approved dose, so these are the patterns clinics and the skincare community actually follow — reported here for information, not as medical advice.
Topical (standard)
1–3% serum, 1–2×/day
The everyday use. Apply to clean skin; judge results over 8–12 weeks.
Layering rule
Don't mix with acids in the same layer
Strong vitamin C, AHAs/BHAs and high-strength retinol can break the copper bond — alternate days/nights instead.
Injectable (clinic)
~1–2 mg/day or 2 mg 3×/wk, subQ, 4–8 wk cycles
The dosing pattern reported across peptide-clinic protocol guides for healing & hair use, provider-administered; bypasses the skin-absorption problem. No regulator has verified this number — it's what clinics report using, not an approved label dose.
Critical caveat
No regulator-verified human dose
The injectable route hasn't been through a formal review, in the US or elsewhere — see the "why" in Regulatory below. Self-injecting gray-market vials without medical supervision risks infection and copper overload — see Side Effects.
Two different legal worlds: the topical cosmetic is fully legal and on store shelves. The injectable is unresolved — but "not FDA-approved" is a regulatory-paperwork status, not a verdict on whether it works. GHK-Cu is a 50-year-old, naturally-occurring peptide nobody can patent — and no company will spend the $50–100M a modern injectable drug trial costs on a molecule it can't own the exclusive rights to sell. That's the real reason human injectable trials don't exist, in the US or anywhere else — not a finding that it's unsafe or ineffective.
FDA — Cosmetic
Legal as "Copper Tripeptide-1"
Topical copper-peptide serums are sold legally as cosmetics. The FDA doesn't pre-approve cosmetic ingredients for efficacy, so "works" claims aren't FDA-verified — but the products themselves are legal to buy and sell.
FDA — Injectable
Unresolved paperwork, not a safety verdict
No injectable GHK-Cu carries FDA drug approval — but nobody has ever run the injectable through the approval pipeline, because that pipeline is built for patent-protected drugs a company can recoup $50M+ on. It was pulled off the compounding "Category 2" restricted list on April 15, 2026 (removed, not banned) after HHS Secretary RFK Jr's February 2026 peptide-reclassification push; a formal Pharmacy Compounding Advisory Committee review of the injectable route specifically is set for February 2027. Read "not approved" as "not yet reviewed," not "reviewed and rejected."
WADA — Sport (Global)
NOT on the 2026 banned list
GHK-Cu is not named on WADA's 2026 Prohibited List, which governs athletes worldwide, not just the US — a notable contrast with the peptides it's often shelved next to (BPC-157 and TB-500), which are restricted/banned. Athletes should still confirm with their sport's authority.
Set the controlled research against what credentialed people actually say. Real-world use: copper peptide blew up on TikTok around 2024–2025; users widely report a "glow," smoother texture and calmer skin from serums, while an injectable community trades healing and hair anecdotes with little hard data. Below, the two voices that matter most — the biochemist who discovered it, and a board-certified dermatologist — each measured against PubMed.
Loren Pickart, PhD
Biochemist · discovered GHK (1973) · Skin Biology, WA
The field's founder. His reviews argue GHK-Cu is a master repair signal: it regulates ~4,000 genes, rebuilds collagen/elastin, heals many tissues, and helps "reset" aging cells toward health — positioning it as a broad anti-aging and regenerative agent.
vs PubMed: the mechanism and animal/cell data strongly back him. The bigger systemic anti-aging claims rest mostly on lab/animal work and his own reviews — and he founds & sells copper-peptide products, a real commercial interest to weigh.
Dr. Jennifer Gordon, MD
Board-Certified Dermatologist · Westlake Dermatology
The measured clinician. She agrees the science is real — copper peptides do support collagen, healing, and the skin barrier — but warns: "While GHK-Cu peptides can provide some benefits, they are usually not as profound as what is marketed online." Not a retinoid replacement; effects are gradual and subtle.
vs PubMed: a clean match. The literature shows a genuine mechanism and modest human cosmetic signal — and a lack of independent placebo-controlled RCTs. "Supportive, restorative, gradual" is exactly what the data support.
The risk depends entirely on how you use it. The topical serum is low-risk for most people. The injectable is the one to take seriously — copper isn't something you want to overload.
Topical: usually mild
Most people tolerate copper-peptide serums well. Possible: mild redness or stinging, and breakouts in acne-prone skin. True copper-allergy contact dermatitis is uncommon. Patch-test a new product first.
Don't layer with acids
High-strength vitamin C, AHAs/BHAs and strong retinol can chemically break the copper bond in the same application — reducing the effect or causing irritation. Use them at different times of day, not stacked.
Injectable: real risks
Self-injecting gray-market vials carries infection and sterility risk, and copper toxicity if overdosed — in extreme cases requiring IV chelation. There's no established safe human dose. A provider, not a vendor.
Who should avoid it
People with Wilson's disease or Menkes (copper-metabolism disorders) or a known copper allergy; anyone with active/uncontrolled cancer (relative — it promotes cell growth); and pregnancy/breastfeeding (unstudied).
The one thing to remember: the topical serum is low-risk — enjoy it. The
injectable form is where caution belongs: it isn't FDA-approved, has no established human dose, and copper overload is a real (if rare) danger. If you want the injectable route, do it through a qualified provider who can dose and monitor it — not a research-peptide vial off the internet.
(Safety summary: Innerbody, Westlake Dermatology.)
The Bottom Line — In Plain English
GHK-Cu is one of the rare skincare ingredients where the science genuinely came before the hype — a copper-carrying peptide your own body makes and loses with age. The catch is that the loudest claims (systemic anti-aging, hair regrowth, miracle injections) run well ahead of the human proof.
What It Is
A natural copper-binding tripeptide (glycine-histidine-lysine) found in your blood — it drops ~60% from age 20 to 60. Cosmetic name: Copper Tripeptide-1.
What It Does
In lab and animal studies it boosts collagen and elastin, calms inflammation, speeds wound healing, and shifts ~4,000 genes toward repair.
How It's Used
Mostly a topical anti-aging serum (1–3%). Also an unregulated injectable for healing and hair, used clinically at ~1–2 mg/day — not yet reviewed by regulators, in the US or anywhere else.
What the Law Says
Legal cosmetic ingredient. Injectable has no FDA drug approval — it's simply never been through the review pipeline, which is set for a specific injectable-route review in Feb 2027. NOT banned by WADA (globally) — unlike BPC-157 / TB-500.
The Honest Verdict
Real, useful, gentle — for skin, backed by genuine mechanism and modest human cosmetic trials. Wound science is strong but mostly animal. The injectable's thin human-trial record reflects money (nobody can patent it, so nobody funds a $50M+ trial), not a finding that it fails or harms — weigh that honestly against the real, if low, risk of unsupervised self-injection.
- Best-supported real use is topical skin / anti-aging — firmer, smoother skin over weeks, not overnight, and one of the gentler active ingredients out there.
- The quiet catch: plain GHK-Cu barely crosses intact skin, so the formulation matters — a cheap, badly-made serum may do little.
- Wound-healing biology is genuinely strong — but mostly animal and lab, not modern human trials.
- For hair, results come from 6-ingredient injectable cocktails in a 1,000-patient Indian clinical trial — you can't credit copper peptide alone; minoxidil/finasteride still own the stand-alone evidence.
- The injectable's evidence gap is an economics story, not a safety verdict — a naturally-occurring, unpatentable peptide has no company willing to fund the trial. That cuts both ways: treat the lack of data as a real unknown, not proof of danger, but also don't assume "not approved yet" means "approved and safe at any dose."
- Don't layer topicals with vitamin C or acids; and treat the injectable with respect — provider only, copper toxicity is real if overdosed.
- Upsides: cheap, no WADA ban anywhere in the world, low-risk topically, and it's something your body already makes.
This page is general information for the person deciding, not medical advice. According to PubMed; full citations and DOIs below.